Richard Durbin and Michael Stratton, researchers at the Wellcome Trust Sanger Institute, are among 66 life scientists who have been elected as new members of the European Molecular Biology Organization.
Durbin is a principal investigator at the Sanger Institute as well as co-chair of the 1000 Genomes Project's steering committee.
Stratton is deputy director of the Sanger Institute and head of its Cancer Genome Project.
CLC Bio has appointed David Leangen as head of its operations in Japan. Originally from Canada, Leangen is a "long-time Japan resident with great experience in the Japanese life science sector," according to the company.
Amanda Clardy has been named chief marketing officer of Life Technologies. Her role as head of investor relations will be taken over by Eileen Pattinson, who joined Life Tech's predecessor Invitrogen in 2005, where she has held various leadership positions.